Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	FBLN2 FBN1 FBN2	6.45e-06	12	63	3	GO:0030023
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	FBLN2 FBN1 FBN2	1.06e-05	14	63	3	GO:0097493
GeneOntologyMolecularFunction	calcium ion binding	CACNA1B FBLN1 FAT1 FBLN2 FBN1 FBN2 MACF1 LTBP1 CPS1 LDLR RYR1	1.99e-05	749	63	11	GO:0005509
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FBLN1 FBLN2 FBN1 FBN2 LTBP1	3.17e-04	188	63	5	GO:0005201
GeneOntologyMolecularFunction	serotonin binding	HTR1F HTR2A	7.47e-04	13	63	2	GO:0051378
GeneOntologyBiologicalProcess	sequestering of TGFbeta in extracellular matrix	FBN1 FBN2 LTBP1	1.08e-07	4	63	3	GO:0035583
GeneOntologyBiologicalProcess	maintenance of protein location in extracellular region	FBN1 FBN2 LTBP1	1.50e-06	8	63	3	GO:0071694
GeneOntologyBiologicalProcess	sequestering of extracellular ligand from receptor	FBN1 FBN2 LTBP1	4.40e-06	11	63	3	GO:0035581
GeneOntologyBiologicalProcess	extracellular regulation of signal transduction	FBN1 FBN2 LTBP1	7.60e-06	13	63	3	GO:1900115
GeneOntologyBiologicalProcess	extracellular negative regulation of signal transduction	FBN1 FBN2 LTBP1	7.60e-06	13	63	3	GO:1900116
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	9.18e-06	2	63	2	GO:0036309
GeneOntologyBiologicalProcess	response to purine-containing compound	AKAP9 PRKAA2 BIRC2 CPS1 RYR1	1.53e-04	166	63	5	GO:0014074
GeneOntologyCellularComponent	microfibril	FBN1 FBN2 LTBP1	7.30e-06	13	63	3	GO:0001527
GeneOntologyCellularComponent	RNA polymerase III transcription regulator complex	BDP1 GTF3C1	3.17e-04	9	63	2	GO:0090576
MousePheno	abnormal B-2 B cell morphology	COG6 PIK3CD BACH2 FNIP1	1.81e-05	41	54	4	MP:0008166
MousePheno	decreased marginal zone B cell number	COG6 PIK3CD BACH2 FNIP1	8.26e-05	60	54	4	MP:0008182
MousePheno	increased enzyme/coenzyme level	FBN2 PSAP AKAP9 LUC7L3 ARVCF COG6 DIPK1A BACH2 MKRN2 PRKAA2 PAK2 SPOP LDLR BTRC	8.37e-05	1148	54	14	MP:0014448
MousePheno	abnormal KLRG1+ CD4 alpha-beta T cell number	COG6 BACH2	8.74e-05	4	54	2	MP:0013156
MousePheno	increased KLRG1+ CD4 alpha-beta T cell number	COG6 BACH2	8.74e-05	4	54	2	MP:0013157
MousePheno	increased KLRG1+ CD8 alpha-beta T cell number	COG6 BACH2	8.74e-05	4	54	2	MP:0013154
MousePheno	abnormal KLRG1+ CD8 alpha-beta T cell number	COG6 BACH2	1.45e-04	5	54	2	MP:0013153
MousePheno	alveolitis	FBN1 LYST	2.18e-04	6	54	2	MP:0010922
MousePheno	decreased Ly6C-positive immature NK cell number	COG6 BACH2	2.18e-04	6	54	2	MP:0013669
MousePheno	decreased memory-marker NK cell number	COG6 BACH2	2.18e-04	6	54	2	MP:0013426
MousePheno	abnormal enzyme/coenzyme level	FBN2 PSAP AKAP9 LUC7L3 ARVCF COG6 DIPK1A BACH2 MKRN2 PRKAA2 PAK2 LTBP1 SPOP LDLR BTRC	2.81e-04	1451	54	15	MP:0005319
MousePheno	increased KLRG1-positive NK cell number	COG6 BACH2	3.04e-04	7	54	2	MP:0012767
MousePheno	abnormal Ly6C-positive immature NK cell number	COG6 BACH2	3.04e-04	7	54	2	MP:0013668
MousePheno	abnormal KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	COG6 BACH2	3.04e-04	7	54	2	MP:0013431
MousePheno	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	COG6 BACH2	3.04e-04	7	54	2	MP:0013433
MousePheno	increased circulating enzyme level	FBN2 AKAP9 LUC7L3 ARVCF COG6 DIPK1A BACH2 MKRN2 PRKAA2 PAK2 SPOP LDLR BTRC	3.09e-04	1140	54	13	MP:0014450
MousePheno	decreased B-2 B cell number	PIK3CD BACH2 FNIP1	3.55e-04	36	54	3	MP:0008207
MousePheno	overexpanded pulmonary alveolus	FBLN1 FBN1 LYST	3.86e-04	37	54	3	MP:0001183
MousePheno	abnormal platelet morphology	TUT4 FBN1 FBN2 COG6 KIAA0232 BACH2 PRKAA2 CPS1 LYST	4.39e-04	600	54	9	MP:0004720
MousePheno	abnormal phagocyte morphology	BDP1 USP45 FBN1 PSAP COG6 PIK3CD BACH2 FNIP1 CPS1 LYST LDLR BTRC	4.68e-04	1033	54	12	MP:0008251
MousePheno	abnormal marginal zone B cell morphology	COG6 PIK3CD BACH2 FNIP1	5.08e-04	96	54	4	MP:0008180
MousePheno	decreased Ly6C-positive mature NK cell number	COG6 BACH2	5.18e-04	9	54	2	MP:0013675
MousePheno	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	COG6 BACH2	5.18e-04	9	54	2	MP:0013430
MousePheno	increased memory-marker NK cell number	COG6 BACH2	5.18e-04	9	54	2	MP:0013427
MousePheno	decreased memory-marker CD4-negative NK T cell number	COG6 BACH2	5.18e-04	9	54	2	MP:0013513
MousePheno	abnormal circulating enzyme level	FBN2 AKAP9 LUC7L3 ARVCF COG6 DIPK1A BACH2 MKRN2 PRKAA2 PAK2 LTBP1 SPOP LDLR BTRC	5.42e-04	1372	54	14	MP:0001570
MousePheno	impaired lung alveolus development	FBLN1 FBN1 LYST	6.45e-04	44	54	3	MP:0006027
MousePheno	intracerebral hemorrhage	FBLN1 CFAP54 COG6	6.45e-04	44	54	3	MP:0001916
MousePheno	abnormal memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	COG6 BACH2	6.46e-04	10	54	2	MP:0013428
MousePheno	decreased CD4-negative NK T cell number	COG6 BACH2	6.46e-04	10	54	2	MP:0013510
MousePheno	abnormal neutrophil morphology	BDP1 USP45 FBN1 PIK3CD BACH2 FNIP1 CPS1 LYST	7.14e-04	511	54	8	MP:0005065
MousePheno	decreased transitional stage B cell number	COG6 BACH2 FNIP1	7.35e-04	46	54	3	MP:0008190
MousePheno	enhanced autophagy	PSAP FNIP1	7.88e-04	11	54	2	MP:0030941
MousePheno	increased Ly6C high monocyte number	COG6 BACH2	7.88e-04	11	54	2	MP:0013022
MousePheno	abnormal grip strength	CACNA1B FBN2 LUC7L3 BACH2 SCAPER FNIP1 SPOP CPS1 LYST LDLR RYR1	8.34e-04	946	54	11	MP:0001515
MousePheno	abnormal lung alveolus development	FBLN1 FBN1 LYST	9.39e-04	50	54	3	MP:0010995
MousePheno	abnormal Ly6C-positive mature NK cell number	COG6 BACH2	9.43e-04	12	54	2	MP:0013674
MousePheno	increased skeletal muscle cell glucose uptake	ANK2 PRKAA2	9.43e-04	12	54	2	MP:0031619
MousePheno	abnormal memory-marker NK cell number	COG6 BACH2	9.43e-04	12	54	2	MP:0013425
MousePheno	ostium secundum atrial septal defect	FBLN1 RYR1	9.43e-04	12	54	2	MP:0010405
Domain	EGF_CA	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	1.54e-08	86	63	7	PF07645
Domain	cEGF	FBLN1 FBLN2 FBN1 FBN2 LTBP1	2.31e-08	26	63	5	IPR026823
Domain	cEGF	FBLN1 FBLN2 FBN1 FBN2 LTBP1	2.31e-08	26	63	5	PF12662
Domain	EGF_Ca-bd_CS	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	3.57e-08	97	63	7	IPR018097
Domain	EGF_CA	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	4.12e-08	99	63	7	PS01187
Domain	ASX_HYDROXYL	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	4.41e-08	100	63	7	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	6.62e-08	106	63	7	IPR000152
Domain	EGF_CA	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	1.74e-07	122	63	7	SM00179
Domain	EGF-like_Ca-bd_dom	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	1.95e-07	124	63	7	IPR001881
Domain	Growth_fac_rcpt_	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	9.26e-07	156	63	7	IPR009030
Domain	TB	FBN1 FBN2 LTBP1	1.27e-06	7	63	3	PF00683
Domain	-	FBN1 FBN2 LTBP1	2.02e-06	8	63	3	3.90.290.10
Domain	TB	FBN1 FBN2 LTBP1	3.03e-06	9	63	3	PS51364
Domain	TB_dom	FBN1 FBN2 LTBP1	3.03e-06	9	63	3	IPR017878
Domain	EGF_3	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	1.39e-05	235	63	7	PS50026
Domain	EGF	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	1.39e-05	235	63	7	SM00181
Domain	EGF-like_dom	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	2.02e-05	249	63	7	IPR000742
Domain	EGF_1	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	2.35e-05	255	63	7	PS00022
Domain	EGF-like_CS	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	2.73e-05	261	63	7	IPR013032
Domain	EGF_2	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	3.00e-05	265	63	7	PS01186
Domain	FBN	FBN1 FBN2	3.35e-05	3	63	2	IPR011398
Domain	ARM-type_fold	RIF1 ARVCF PIK3CD MROH2A CTIF USP9Y LYST	1.41e-04	339	63	7	IPR016024
Domain	ANATO	FBLN1 FBLN2	2.33e-04	7	63	2	SM00104
Domain	ANATO	FBLN1 FBLN2	2.33e-04	7	63	2	PF01821
Domain	ANAPHYLATOXIN_2	FBLN1 FBLN2	2.33e-04	7	63	2	PS01178
Domain	ANAPHYLATOXIN_1	FBLN1 FBLN2	2.33e-04	7	63	2	PS01177
Domain	Anaphylatoxin/fibulin	FBLN1 FBLN2	2.33e-04	7	63	2	IPR000020
Domain	5HT_rcpt	HTR1F HTR2A	3.97e-04	9	63	2	IPR002231
Domain	MATH/TRAF_dom	SPOPL SPOP	7.23e-04	12	63	2	IPR002083
Domain	MATH	SPOPL SPOP	7.23e-04	12	63	2	PS50144
Domain	MATH	SPOPL SPOP	7.23e-04	12	63	2	SM00061
Domain	MATH	SPOPL SPOP	7.23e-04	12	63	2	PF00917
Domain	bZIP_Maf	BACH2 BACH1	8.53e-04	13	63	2	IPR004826
Domain	bZIP_Maf	BACH2 BACH1	8.53e-04	13	63	2	PF03131
Domain	-	SPOPL SPOP	9.93e-04	14	63	2	2.60.210.10
Domain	BTB	SPOPL BACH2 BACH1 SPOP	1.00e-03	131	63	4	PF00651
Domain	-	BACH2 BACH1	1.30e-03	16	63	2	1.10.880.10
Domain	BTB	SPOPL BACH2 BACH1 SPOP	2.09e-03	160	63	4	PS50097
Domain	TRAF-like	SPOPL SPOP	2.95e-03	24	63	2	IPR008974
Domain	BTB	SPOPL BACH2 BACH1 SPOP	3.19e-03	180	63	4	SM00225
Domain	DHHC	ZDHHC21 KMT2C	3.20e-03	25	63	2	PS50216
Domain	Znf_DHHC_palmitoyltrfase	ZDHHC21 KMT2C	3.20e-03	25	63	2	IPR001594
Domain	ZF_RING_2	KMT2C VPS18 MKRN2 NFXL1 BIRC2	3.30e-03	298	63	5	PS50089
Domain	BTB/POZ_dom	SPOPL BACH2 BACH1 SPOP	3.52e-03	185	63	4	IPR000210
Domain	SKP1/BTB/POZ	SPOPL BACH2 BACH1 SPOP	3.80e-03	189	63	4	IPR011333
Domain	Znf_RING	KMT2C VPS18 MKRN2 NFXL1 BIRC2	4.83e-03	326	63	5	IPR001841
Domain	bZIP_1	BACH2 BACH1	5.86e-03	34	63	2	PF00170
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBLN1 FBLN2 FBN1 FBN2 LTBP1	1.83e-07	37	50	5	M27134
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBLN1 FBLN2 FBN1 FBN2 LTBP1	4.47e-07	44	50	5	M26969
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBLN2 FBN1 FBN2 LTBP1	4.68e-06	32	50	4	MM14854
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBLN2 FBN1 FBN2 LTBP1	1.05e-05	39	50	4	MM14601
Pathway	WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE	FBN1 FBN2 LTBP1	9.14e-05	25	50	3	M39713
Pubmed	Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.	FBN1 FBN2 LTBP1	2.26e-08	4	63	3	12429738
Pubmed	POGLUT2 and POGLUT3 O-glucosylate multiple EGF repeats in fibrillin-1, -2, and LTBP1 and promote secretion of fibrillin-1.	FBN1 FBN2 LTBP1	5.65e-08	5	63	3	34411563
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	DNAJA3 FBLN1 VPS18 TUT4 FBLN2 FBN1 COG6 KIAA0232 PEX19 LTBP1	6.43e-08	560	63	10	21653829
Pubmed	Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.	FBLN2 FBN1 LTBP1	1.13e-07	6	63	3	19349279
Pubmed	EMILIN proteins are novel extracellular constituents of the dentin-pulp complex.	FBLN1 FBLN2 FBN1	3.15e-07	8	63	3	32948785
Pubmed	Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.	FBLN1 FBN1 FBN2	4.72e-07	9	63	3	12122015
Pubmed	Poglut2/3 double knockout in mice results in neonatal lethality with reduced levels of fibrillin in lung tissues.	FBN1 FBN2 LTBP1	4.72e-07	9	63	3	38844137
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	FBLN1 FBLN2 FBN1 FBN2 LTBP1	5.16e-07	86	63	5	28327460
Pubmed	Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils.	FBN1 FBN2	3.23e-06	2	63	2	12399449
Pubmed	Fibrillin-1 and fibrillin-2 are essential for formation of thick oxytalan fibers in human nonpigmented ciliary epithelial cells in vitro.	FBN1 FBN2	3.23e-06	2	63	2	21851253
Pubmed	Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences.	FBN1 FBN2	3.23e-06	2	63	2	12429739
Pubmed	Confocal laser scanning analysis of the association of fibulin-2 with fibrillin-1 and fibronectin define different stages of skin regeneration.	FBLN2 FBN1	3.23e-06	2	63	2	9886271
Pubmed	Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.	FBLN1 LTBP1	3.23e-06	2	63	2	31343988
Pubmed	New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis.	FBN1 FBN2	3.23e-06	2	63	2	30044367
Pubmed	Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils.	FBN1 FBN2	3.23e-06	2	63	2	21440062
Pubmed	MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils.	FBN1 FBN2	3.23e-06	2	63	2	15131124
Pubmed	A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor.	SPOPL SPOP	3.23e-06	2	63	2	16740475
Pubmed	Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo.	FBLN1 FBLN2	3.23e-06	2	63	2	8850569
Pubmed	Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development.	FBN1 FBN2	3.23e-06	2	63	2	12524050
Pubmed	AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.	PRKAA2 LDLR	3.23e-06	2	63	2	20167927
Pubmed	Evolutionary expansion of SPOP and associated TD/POZ gene family: impact of evolutionary route on gene expression pattern.	SPOPL SPOP	3.23e-06	2	63	2	20399258
Pubmed	Microfibril structure masks fibrillin-2 in postnatal tissues.	FBN1 FBN2	3.23e-06	2	63	2	20404337
Pubmed	The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1.	FBN1 LTBP1	3.23e-06	2	63	2	28669633
Pubmed	Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia.	BACH2 BACH1	3.23e-06	2	63	2	30250186
Pubmed	Fibrillln mutations in Marfan syndrome and related phenotypes.	FBN1 FBN2	3.23e-06	2	63	2	8791520
Pubmed	Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.	FBN1 FBN2	3.23e-06	2	63	2	8120105
Pubmed	The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.	FBN1 FBN2	3.23e-06	2	63	2	35419902
Pubmed	Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18.	FBN1 FBN2	3.23e-06	2	63	2	8307578
Pubmed	Bach2 is involved in neuronal differentiation of N1E-115 neuroblastoma cells.	BACH2 BACH1	3.23e-06	2	63	2	16631738
Pubmed	Fibrillin assembly: dimer formation mediated by amino-terminal sequences.	FBN1 FBN2	3.23e-06	2	63	2	10504303
Pubmed	Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.	FBN1 FBN2	3.23e-06	2	63	2	7744963
Pubmed	Crystal structure of the Bach1 BTB domain and its regulation of homodimerization.	BACH2 BACH1	3.23e-06	2	63	2	19170764
Pubmed	Fibrillin microfibrils in bone physiology.	FBN1 FBN2	3.23e-06	2	63	2	26408953
Pubmed	Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration.	FBN1 FBN2	3.23e-06	2	63	2	18006876
Pubmed	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis.	FBN1 FBN2	3.23e-06	2	63	2	24833718
Pubmed	Localization and phenotype-specific expression of ryanodine calcium release channels in C57BL6 and DBA/2J mouse strains.	GPNMB RYR1	3.23e-06	2	63	2	21933672
Pubmed	Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues.	FBLN2 FBN1	3.23e-06	2	63	2	8702639
Pubmed	Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome.	FBN1 FBN2	3.23e-06	2	63	2	24265020
Pubmed	In vivo studies of mutant fibrillin-1 microfibrils.	FBN1 FBN2	3.23e-06	2	63	2	20529844
Pubmed	Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development.	FBN1 FBN2	3.23e-06	2	63	2	25524144
Pubmed	The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo.	FBLN1 FBLN2	3.23e-06	2	63	2	8737292
Pubmed	The double knockout of Bach1 and Bach2 in mice reveals shared compensatory mechanisms in regulating alveolar macrophage function and lung surfactant homeostasis.	BACH2 BACH1	3.23e-06	2	63	2	27387751
Pubmed	Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions.	FBN1 FBN2	3.23e-06	2	63	2	23133647
Pubmed	Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases.	FBLN1 FBLN2	3.23e-06	2	63	2	8841408
Pubmed	Fibrillins 1 and 2 perform partially overlapping functions during aortic development.	FBN1 FBN2	3.23e-06	2	63	2	16407178
Pubmed	Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.	FBN1 FBN2	3.23e-06	2	63	2	1852206
Pubmed	N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.	FBN1 FBN2	3.23e-06	2	63	2	10359653
Pubmed	Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells.	FBLN1 FBLN2	3.23e-06	2	63	2	19609566
Pubmed	Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice.	LYST LDLR	3.23e-06	2	63	2	15175354
Pubmed	Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus.	SPOPL SPOP	3.23e-06	2	63	2	16651542
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DNAJA3 FAT1 TUT4 FBN2 BACH2 SCAPER BIRC2 MACF1 SPOP TADA2A LDLR	4.72e-06	1116	63	11	31753913
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	DNAJA3 VPS18 AKAP9 GTF3C1 PRKAA2 BUB1 SCAPER BIRC2 LYST BTRC	5.22e-06	910	63	10	36736316
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	FBLN1 FBLN2 FBN1 PSAP LTBP1 LDLR	5.98e-06	248	63	6	24006456
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	FBLN1 FBLN2 FBN1 PSAP LTBP1	7.03e-06	146	63	5	27068509
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	RIF1 FBN1 FBN2 NFXL1	8.67e-06	71	63	4	33541421
Pubmed	Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly.	FBN1 FBN2	9.68e-06	3	63	2	10825173
Pubmed	Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice.	PSAP RYR1	9.68e-06	3	63	2	27655403
Pubmed	Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting.	CACNA1B ANK2	9.68e-06	3	63	2	24394417
Pubmed	Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage.	FBN1 FBN2	9.68e-06	3	63	2	30201140
Pubmed	Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.	ANK2 OBSCN	9.68e-06	3	63	2	12527750
Pubmed	A Bach2-Cebp Gene Regulatory Network for the Commitment of Multipotent Hematopoietic Progenitors.	BACH2 BACH1	9.68e-06	3	63	2	28273455
Pubmed	The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.	BACH2 BACH1	9.68e-06	3	63	2	25344725
Pubmed	Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors.	HTR1F HTR2A	9.68e-06	3	63	2	15190056
Pubmed	Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts.	PSAP PAK2	9.68e-06	3	63	2	15047825
Pubmed	Association analysis of TPH2, 5-HT2A, and 5-HT6 with executive function in a young Chinese Han population.	HTR1F HTR2A	9.68e-06	3	63	2	21457069
Pubmed	Glucocorticoids down-regulate the extracellular matrix proteins fibronectin, fibulin-1 and fibulin-2 in bone marrow stroma.	FBLN1 FBLN2	9.68e-06	3	63	2	11737251
Pubmed	A scanning electron microscopic investigation of genetic emphysema in tight-skin, pallid, and beige mice, three different C57 BL/6J mutants.	FBN1 LYST	9.68e-06	3	63	2	8780155
Pubmed	Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.	PRKAA2 LDLR	9.68e-06	3	63	2	20124121
Pubmed	The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study.	FBLN1 FBN1	9.68e-06	3	63	2	7534784
Pubmed	LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein.	FBN1 LTBP1	9.68e-06	3	63	2	17293099
Pubmed	Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.	ANK2 OBSCN	9.68e-06	3	63	2	18782775
Pubmed	Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.	FBN1 LYST	9.68e-06	3	63	2	8166647
Pubmed	Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.	FBN1 FBN2	9.68e-06	3	63	2	20855508
Pubmed	c-IAP1 binds and processes PCSK9 protein: linking the c-IAP1 in a TNF-α pathway to PCSK9-mediated LDLR degradation pathway.	DNAJA3 BIRC2 LDLR	1.12e-05	24	63	3	23085658
Pubmed	Functional proteomics mapping of a human signaling pathway.	DNAJA3 FBLN1 KANK1 FBN2 PSAP PEX19 MACF1 GPNMB	1.13e-05	591	63	8	15231748
Pubmed	Ultrastructural localization of microfibrillar fibulin-1 and fibulin-2 during heart development indicates a switch in molecular associations.	FBLN1 FBLN2	1.93e-05	4	63	2	9676579
Pubmed	Human eye development is characterized by coordinated expression of fibrillin isoforms.	FBN1 FBN2	1.93e-05	4	63	2	25406291
Pubmed	Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2.	BACH2 BACH1	1.93e-05	4	63	2	21444915
Pubmed	Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.	FBN1 FBN2	1.93e-05	4	63	2	20729550
Pubmed	AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.	PRKAA2 LDLR	1.93e-05	4	63	2	21459323
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN2	1.93e-05	4	63	2	25034023
Pubmed	Forelimb contractures and abnormal tendon collagen fibrillogenesis in fibulin-4 null mice.	FBLN1 FBLN2	1.93e-05	4	63	2	26711913
Pubmed	A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain.	BACH2 BACH1	1.93e-05	4	63	2	10669750
Pubmed	Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes.	FBN1 FBN2	1.93e-05	4	63	2	16835936
Pubmed	Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1.	PRKAA2 FNIP1	1.93e-05	4	63	2	37079666
Pubmed	Association study of seven polymorphisms in four serotonin receptor genes on suicide victims.	HTR1F HTR2A	1.93e-05	4	63	2	16856120
Pubmed	Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations.	LYST LDLR	1.93e-05	4	63	2	12171798
Pubmed	Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering.	FBLN2 FBN1	1.93e-05	4	63	2	15610515
Pubmed	Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.	FBLN1 FBLN2	1.93e-05	4	63	2	10022829
Pubmed	ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation.	FBN1 FBN2 LTBP1	2.22e-05	30	63	3	32882513
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KMT2C USP45 PSAP SPOPL PIK3CD DIPK1A OBSCN NFXL1 MACF1 LDLR	2.37e-05	1084	63	10	11544199
Pubmed	Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.	FBN1 FBN2 LTBP1	2.46e-05	31	63	3	25762570
Pubmed	Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?	HTR2A PIK3CD PRKAA2 TADA2A LDLR	2.64e-05	192	63	5	20602615
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	ZDHHC21 VPS18 HTR2A BACH2 BACH1	2.70e-05	193	63	5	22589738
Pubmed	Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin- and Fibrillin-binding Protein Involved in Elastic Fiber Formation.	FBN1 FBN2	3.22e-05	5	63	2	26601954
Pubmed	Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.	IL10RB LDLR	3.22e-05	5	63	2	30291029
Pubmed	Relaxin regulates fibrillin 2, but not fibrillin 1, mRNA and protein expression by human dermal fibroblasts and murine fetal skin.	FBN1 FBN2	3.22e-05	5	63	2	12590922
Pubmed	Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase.	SPOPL SPOP	3.22e-05	5	63	2	22632832
Pubmed	Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin.	FBN1 FBN2	3.22e-05	5	63	2	17255108
Pubmed	A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects.	FBLN1 FBLN2	3.22e-05	5	63	2	11290292
Interaction	MFAP5 interactions	FBLN1 FBN1 FBN2 KIAA0232 LDLR	5.44e-07	52	62	5	int:MFAP5
Interaction	NTN5 interactions	FBN1 FBN2 LTBP1 LDLR	8.24e-07	24	62	4	int:NTN5
Interaction	ZFP41 interactions	FBLN1 FBN1 FBN2 LTBP1 LDLR	8.66e-07	57	62	5	int:ZFP41
Interaction	ELN interactions	FBLN1 FBLN2 FBN1 FBN2	1.82e-06	29	62	4	int:ELN
Interaction	ZNF408 interactions	FBLN2 FBN1 FBN2 KIAA0232 LTBP1 LDLR	5.52e-06	145	62	6	int:ZNF408
Interaction	FNIP1 interactions	AKAP9 PRKAA2 FNIP1 BTRC	7.55e-06	41	62	4	int:FNIP1
Interaction	LTBP1 interactions	FBLN2 FBN1 FBN2 PSAP LTBP1	9.36e-06	92	62	5	int:LTBP1
Interaction	SFRP4 interactions	FBLN1 FBN2 BUB1 BTRC	1.55e-05	49	62	4	int:SFRP4
Interaction	FBN1 interactions	FBLN2 FBN1 FBN2 LTBP1	1.82e-05	51	62	4	int:FBN1
Interaction	LYPD4 interactions	VPS18 FAT1 FBN2 DIPK1A OBSCN	3.82e-05	123	62	5	int:LYPD4
Interaction	FBLN2 interactions	FBLN1 FBLN2 FBN1 LTBP1	5.07e-05	66	62	4	int:FBLN2
Interaction	BRINP3 interactions	FAT1 KIAA0232 BUB1	6.08e-05	25	62	3	int:BRINP3
Interaction	DUSP16 interactions	VPS18 TUT4 COG6 KIAA0232 BUB1 FIGNL1	8.80e-05	237	62	6	int:DUSP16
Interaction	TAFA3 interactions	FBLN1 FBN2 BIRC2 LDLR	9.77e-05	78	62	4	int:TAFA3
Interaction	CREB5 interactions	FBLN1 SPOPL BACH2 BACH1 SPOP	1.49e-04	164	62	5	int:CREB5
GeneFamily	Fibulins	FBLN1 FBLN2	1.53e-04	8	43	2	556
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	SPOPL BACH2 BACH1 SPOP	2.85e-04	134	43	4	861
GeneFamily	5-hydroxytryptamine receptors, G protein-coupled	HTR1F HTR2A	4.24e-04	13	43	2	170
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	RIF1 FAT1 KANK1 TUT4 AKAP9 KIAA0232 BACH1 BIRC2 SPOP	4.12e-08	300	63	9	M8702
Coexpression	CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE	FAT1 FBN2 PSAP AKAP9 LUC7L3 MACF1 LTBP1	2.47e-07	179	63	7	M39308
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KMT2C RIF1 TUT4 GTF3C1 PIK3CD MACF1 PRR14L	2.56e-07	180	63	7	M8239
Coexpression	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP	KIAA0232 BUB1 TADA2A FIGNL1 LDLR RYR1	8.66e-06	200	63	6	M4327
Coexpression	DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC	FBLN2 FBN2 LTBP1	3.71e-05	27	63	3	M47994
Coexpression	BOQUEST_STEM_CELL_UP	FBLN1 FAT1 FBN1 ANK2 DIPK1A GPNMB	3.89e-05	261	63	6	M1834
Coexpression	NABA_ECM_GLYCOPROTEINS	FBLN1 FBLN2 FBN1 FBN2 LTBP1	9.73e-05	191	63	5	MM17059
Coexpression	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	DIPK1A BACH2 TESPA1	1.05e-04	38	63	3	M1751
Coexpression	NABA_ECM_GLYCOPROTEINS	FBLN1 FBLN2 FBN1 FBN2 LTBP1	1.10e-04	196	63	5	M3008
Coexpression	GSE27786_LIN_NEG_VS_BCELL_DN	TUT4 DIPK1A SCAPER SPOP LYST	1.21e-04	200	63	5	M4768
Coexpression	KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP	PSAP AKAP9 GTF3C1 BIRC2 LDLR	1.21e-04	200	63	5	M3020
Coexpression	TRAYNOR_RETT_SYNDROM_UP	FBLN1 FNIP1 LTBP1	1.23e-04	40	63	3	M2712
Coexpression	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	DIPK1A BACH2 TESPA1	1.42e-04	42	63	3	MM733
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	FAT1 KANK1 LUC7L3 BACH1 MACF1	1.59e-04	212	63	5	M39221
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	ZDHHC21 RIF1 CFAP54 TUT4 AKAP9 ANK2 LUC7L3 ARVCF PIK3CD ICE2 BUB1 MACF1 CTIF FIGNL1 XKR5	2.76e-07	1060	62	15	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	ZDHHC21 RIF1 CFAP54 TUT4 AKAP9 ANK2 LUC7L3 ARVCF PIK3CD ICE2 BUB1 MACF1 CTIF FIGNL1 XKR5	9.89e-06	1414	62	15	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	BDP1 USP45 TUT4 AKAP9 COG6 ICE2 BIRC2 FNIP1 MACF1 PRR14L LDLR	1.41e-05	780	62	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C RIF1 PSAP AKAP9 SCAPER FNIP1 MACF1 LDLR	3.40e-10	195	63	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C RIF1 PSAP AKAP9 SCAPER FNIP1 MACF1 LDLR	3.40e-10	195	63	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 AKAP9 ANK2 GTF3C1 MACF1 LTBP1 NRIP3	4.16e-10	200	63	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBLN1 FBLN2 FBN1 ANK2 WSCD2 LTBP1	1.27e-07	165	63	6	4e13fccd32029e2879e85f8966e582a46c09e4aa
ToppCell	356C-Fibroblasts-Fibroblast-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	FBLN1 FBLN2 FBN1 HTR2A LTBP1 CPS1	1.99e-07	178	63	6	a493a277d175e5e153410a745b26ebe2e0839ea0
ToppCell	356C-Fibroblasts-Fibroblast-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	FBLN1 FBLN2 FBN1 HTR2A LTBP1 CPS1	1.99e-07	178	63	6	371218babddfd3d8a7bb82a46ce65327ee3fcf12
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FBLN1 KANK1 FBN1 FBN2 ANK2 WSCD2	2.49e-07	185	63	6	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 HTR2A ANK2 LTBP1	3.10e-07	192	63	6	b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 KANK1 FBLN2 FBN1 LTBP1 GPNMB	3.20e-07	193	63	6	e27885a9e1a2a3e165c5366d4cfcda05c5454483
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 HTR2A ANK2 LTBP1	3.40e-07	195	63	6	51db90e7611f7d69980878c046505ff34212079b
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FAT1 FBN1 ANK2 MROH2A LTBP1	3.50e-07	196	63	6	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FAT1 FBN1 ANK2 MROH2A LTBP1	3.50e-07	196	63	6	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBLN1 FBLN2 FBN1 ANK2 MACF1 LTBP1	3.50e-07	196	63	6	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.60e-07	197	63	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	FBLN1 FBLN2 FBN1 ANK2 BACH2 LTBP1	3.71e-07	198	63	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBLN1 FBLN2 FBN1 ANK2 MACF1 LTBP1	3.71e-07	198	63	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	distal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FBLN2 FBN1 HTR2A ANK2 LTBP1	3.82e-07	199	63	6	547a7c30abc730af2670aee00c7a6af60426c9ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.82e-07	199	63	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.94e-07	200	63	6	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.94e-07	200	63	6	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.94e-07	200	63	6	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBLN1 FBLN2 FBN1 ANK2 LTBP1 GPNMB	3.94e-07	200	63	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.94e-07	200	63	6	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 AKAP9 ANK2 MACF1 LTBP1	3.94e-07	200	63	6	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBLN1 FBN1 ANK2 MACF1 LTBP1 NRIP3	3.94e-07	200	63	6	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FBLN1 FBLN2 FBN1 ANK2 LTBP1 GPNMB	3.94e-07	200	63	6	7ba292c30d915e66ebc8026fa76492cedf64700e
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBLN1 FBLN2 FBN1 ANK2 BACH2 LTBP1	3.94e-07	200	63	6	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	TUT4 LUC7L3 SCAPER OBSCN MACF1	2.39e-06	151	63	5	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	367C-Fibroblasts-Fibroblast-D-\|367C / Donor, Lineage, Cell class and subclass (all cells)	FBLN1 FBLN2 FBN1 ANK2 LTBP1	2.64e-06	154	63	5	dd3d34f065820e706515a13619f19a5b12734c8e
ToppCell	367C-Fibroblasts-Fibroblast-D\|367C / Donor, Lineage, Cell class and subclass (all cells)	FBLN1 FBLN2 FBN1 ANK2 LTBP1	2.64e-06	154	63	5	4bfda1c41efbb86d829b3797d1168bf2587c3c97
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBLN1 FBLN2 FBN1 ANK2 LTBP1	3.92e-06	167	63	5	fe3338f99f94c0dac37e3d649dfdce82e4a56022
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	4.53e-06	172	63	5	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZDHHC21 BDP1 SPOPL BACH1 LYST	4.65e-06	173	63	5	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN1 FBLN2 FBN1 HTR2A GPNMB	4.65e-06	173	63	5	11e95a60b5f6f07f27154a23203bac431e7528c6
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	FBLN1 FBLN2 FBN1 ANK2 LTBP1	5.06e-06	176	63	5	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	FBLN1 FBLN2 FBN1 ANK2 LTBP1	5.06e-06	176	63	5	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	5.96e-06	182	63	5	d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.12e-06	183	63	5	63294d66e3ccf152ffe5d1237106764c14390b62
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.12e-06	183	63	5	7e5c467fd1b156b928f1611a12ab4affb9f714b7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 FBN2 MROH2A OBSCN CPS1	6.28e-06	184	63	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 HTR2A ANK2	6.28e-06	184	63	5	4a9f798c67b9998bffe44242b210cc1e224ff5b1
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 FBN1 ANK2 WSCD2 GPNMB	6.28e-06	184	63	5	fea4fe648e9749177d0783443dc26a7df5807883
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	FBLN1 FBLN2 FBN1 BACH2 LTBP1	6.28e-06	184	63	5	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 FBN2 MROH2A OBSCN CPS1	6.28e-06	184	63	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 FBN2 MROH2A OBSCN CPS1	6.28e-06	184	63	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 FBN1 ANK2 WSCD2 GPNMB	6.28e-06	184	63	5	96a8a0a190bc293655fe7d80cbed8119c0da25f2
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 FBN1 ANK2 WSCD2 GPNMB	6.28e-06	184	63	5	780eb72da43527f0c72effac3423ec7384f05f20
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBN2 ANK2 PRKAA2 OBSCN LTBP1	6.45e-06	185	63	5	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CFAP54 FBN2 WSCD2 CTIF	6.45e-06	185	63	5	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CFAP54 FBN2 WSCD2 CTIF	6.45e-06	185	63	5	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBN1 ARVCF WSCD2 TADA2A	6.62e-06	186	63	5	827f2f2ddde315d1e5970dd56f906c555ec699af
ToppCell	facs-Trachea-nan-24m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.80e-06	187	63	5	71385068e3fd0bfa7822ae176113a49460c8636b
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.80e-06	187	63	5	f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.80e-06	187	63	5	1669df899b1759c338ffce196fe009840123cfcd
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 FBN2 GPNMB	6.80e-06	187	63	5	4e553721fa5598cb211f44e3226280b7e6885484
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 FBN2 GPNMB	6.80e-06	187	63	5	d36e7fc6125e7a4310499365022d38f34b757a73
ToppCell	facs-Trachea-nan-24m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.80e-06	187	63	5	b930d5f7d410ac1f340babec5c937388f64cafc0
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 FBN2 GPNMB	6.80e-06	187	63	5	827eae63fabf6892a82ce7779b5f395958d3d628
ToppCell	facs-Trachea-nan-24m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	6.80e-06	187	63	5	e891e571f6bb9433a0046215de6cabd89ed1effc
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	FBLN1 FBLN2 FBN1 ANK2 LTBP1	6.97e-06	188	63	5	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	KANK1 FBN2 ANK2 PRKAA2 OBSCN	7.16e-06	189	63	5	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.16e-06	189	63	5	d531399749409d614adca13d181830c6e3287508
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.16e-06	189	63	5	dde037322c8caec0c04c5be1c1b59a167824ad9f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.53e-06	191	63	5	0fae1c2ef9f83ac7721d0a9d69455bf97eed9257
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 FBN2 LTBP1	7.72e-06	192	63	5	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.72e-06	192	63	5	7b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.72e-06	192	63	5	fc940f91ff8e051631dbf25e6e8d73cf8337eccb
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 FBN2 LTBP1	7.72e-06	192	63	5	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBLN1 FBN1 ANK2 LTBP1 NRIP3	7.72e-06	192	63	5	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBLN1 FBN1 ANK2 MACF1 LTBP1	7.72e-06	192	63	5	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 FBN2 LTBP1	7.72e-06	192	63	5	ac1477433704573f95111eee6263b93668d2845e
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.72e-06	192	63	5	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.72e-06	192	63	5	7a2e79490e4f7058bb76b46c45b5df9f729e3146
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.72e-06	192	63	5	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.72e-06	192	63	5	c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.72e-06	192	63	5	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.72e-06	192	63	5	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	facs-Trachea-24m-Mesenchymal\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.72e-06	192	63	5	e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba
ToppCell	facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.92e-06	193	63	5	733f557bdc80293b40ccdf560f1675793df932d6
ToppCell	facs-MAT-Fat-24m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.92e-06	193	63	5	eb3c46b6fb06dc8708dc3032189b47ed93ee2357
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AKAP9 LUC7L3 SCAPER MACF1 USP9Y	7.92e-06	193	63	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBLN1 FBLN2 FBN1 ANK2 LTBP1	7.92e-06	193	63	5	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	7.92e-06	193	63	5	b45cd02081f97904eaea2d013e1fa980505d060b
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BDP1 AKAP9 BACH1 PAK2 MACF1	8.12e-06	194	63	5	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	8.12e-06	194	63	5	c9e589fe7df6a9b377654581a2aebb607cbb03b9
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.12e-06	194	63	5	35b30bc954750e939f81a9a7498b8bc2ce69a299
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.33e-06	195	63	5	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.33e-06	195	63	5	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.33e-06	195	63	5	9c32756edb54f0c211185d9a98073fe01fd1526a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.33e-06	195	63	5	1236dc60288c7dd91868e86e9174a2dacd3b11b3
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	8.33e-06	195	63	5	773728703bc8969bff0e1de58fe3e1631add0a0a
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN1 FBLN2 FBN1 ANK2 GPNMB	8.33e-06	195	63	5	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.33e-06	195	63	5	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	facs-Heart-LA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FBLN2 FBN1 LTBP1 GPNMB	8.54e-06	196	63	5	8a84aeb1a565dd3e2a690fcaf1ab804f5e253545
ToppCell	IPF-Stromal-Fibroblast\|IPF / Disease state, Lineage and Cell class	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.54e-06	196	63	5	f7ae604ba32b322d86d68b2b54892e7c6ab06c49
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.54e-06	196	63	5	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-E\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	FBLN1 FBLN2 FBN1 PSAP GPNMB	8.75e-06	197	63	5	9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN1 FBLN2 FBN1 ANK2 GPNMB	8.75e-06	197	63	5	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.75e-06	197	63	5	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 FBLN2 FBN1 ANK2 LTBP1	8.75e-06	197	63	5	c747c496ac090309b7f8a3e9d840928f12c83f2f
Computational	Metal / Ca ion binding.	FBLN1 FAT1 FBLN2 FBN1 FBN2 LTBP1 LDLR	5.03e-07	133	40	7	MODULE_324
Computational	Genes upregulated in subsets of cells of a given type within various tumors	RIF1 FAT1 LUC7L3 MACF1	3.35e-05	50	40	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	DRG (dorsal root ganglia) genes.	FBLN1 FAT1 FBLN2 FBN1 BIRC2 LTBP1 GPNMB LDLR	6.95e-05	384	40	8	MODULE_2
Computational	Ovary genes.	FBLN1 FAT1 FBN1 BIRC2 LTBP1 GPNMB LDLR	3.66e-04	368	40	7	MODULE_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 AKAP9 MACF1	7.81e-04	49	40	3	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	KMT2C AKAP9 LUC7L3	7.81e-04	49	40	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 RIF1 MACF1	8.29e-04	50	40	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	sergolexole	FAT1 HTR1F HTR2A	4.36e-06	12	63	3	CID000060262
Drug	5182598; Up 200; 25uM; MCF7; HT_HG-U133A_EA	ARVCF PIK3CD KIAA0232 BACH1 LDLR TESPA1	1.30e-05	187	63	6	868_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	FBLN1 SCAPER PRR14L TADA2A TESPA1 BTRC	1.75e-05	197	63	6	3692_DN
Drug	Lidoflazine [3416-26-0]; Up 200; 8.2uM; PC3; HT_HG-U133A	TUT4 HTR2A BACH1 BUB1 GPNMB BTRC	1.75e-05	197	63	6	5804_UP
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	KANK1 HTR1F ARVCF BACH1 PRR14L TADA2A	1.80e-05	198	63	6	6909_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	FBN1 AKAP9 ANK2 PIK3CD CTIF TADA2A	1.86e-05	199	63	6	3640_UP
Drug	tamibarotene	IL10RB RIF1 FAT1 FBN2 AKAP9 PIK3CD PAK2 MACF1 CTIF	3.65e-05	596	63	9	ctd:C061133
Drug	SDZ 205-557	FAT1 HTR1F HTR2A	3.92e-05	24	63	3	CID000005191
Drug	1-(1-naphthyl)piperazine	FAT1 HTR1F HTR2A	5.02e-05	26	63	3	CID000001342
Drug	ergolines	FAT1 HTR1F HTR2A	5.63e-05	27	63	3	CID003083577
Drug	CP-132,484	HTR1F HTR2A	7.50e-05	5	63	2	CID000132564
Drug	N-methyl-DL-aspartic acid	CACNA1B FAT1 HTR2A AKAP9 PIK3CD ICE2 BIRC2 LDLR RYR1	7.55e-05	655	63	9	CID000004376
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A	FAT1 PSAP MACF1 GPNMB LDLR	8.14e-05	160	63	5	6133_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	ARVCF PIK3CD SCAPER CPS1 LYST	1.31e-04	177	63	5	4821_UP
Drug	CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A	ARVCF PIK3CD CTIF LYST LDLR	1.65e-04	186	63	5	4380_UP
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	BUB1 SCAPER LTBP1 TADA2A BTRC	1.78e-04	189	63	5	5248_DN
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A	ARVCF BACH2 SCAPER LYST LDLR	1.78e-04	189	63	5	4672_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A	AKAP9 BUB1 CTIF NRIP3 LDLR	1.78e-04	189	63	5	1288_DN
Drug	tridecyl-stigmatellin	HTR1F HTR2A SPOP	1.85e-04	40	63	3	CID000448047
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	FBLN1 ARVCF SCAPER TADA2A BTRC	1.91e-04	192	63	5	3382_DN
Drug	estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	ARVCF PIK3CD SCAPER TADA2A BTRC	1.91e-04	192	63	5	5955_UP
Drug	Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	RIF1 FBN2 DIPK1A PRR14L GPNMB	1.96e-04	193	63	5	6691_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; HL60; HG-U133A	FBLN1 PIK3CD BUB1 PEX19 MACF1	1.96e-04	193	63	5	2015_DN
Drug	Meropenem [96036-03-2]; Up 200; 10.4uM; PC3; HT_HG-U133A	FBN2 AKAP9 ARVCF BUB1 CTIF	2.01e-04	194	63	5	5824_UP
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	AKAP9 DIPK1A PRKAA2 CTIF TADA2A	2.01e-04	194	63	5	4264_DN
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ARVCF LTBP1 PRR14L LDLR BTRC	2.01e-04	194	63	5	1480_DN
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	RIF1 FBLN1 ARVCF PRKAA2 TADA2A	2.01e-04	194	63	5	3363_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A	FBLN1 BUB1 SCAPER PAK2 TADA2A	2.01e-04	194	63	5	3689_DN
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A	FBLN1 DIPK1A BUB1 SCAPER LDLR	2.01e-04	194	63	5	4602_DN
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; HL60; HT_HG-U133A	TUT4 AKAP9 BUB1 MACF1 LYST	2.06e-04	195	63	5	2568_DN
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	TUT4 ARVCF PRR14L LDLR BTRC	2.06e-04	195	63	5	3323_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A	TUT4 ANK2 TADA2A GPNMB BTRC	2.06e-04	195	63	5	4016_UP
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	FBLN1 CTIF TADA2A LYST LDLR	2.06e-04	195	63	5	6159_DN
Drug	AC1L5AAF	HTR1F HTR2A	2.09e-04	8	63	2	CID000173615
Drug	N3RdUMP	BDP1 GTF3C1	2.09e-04	8	63	2	CID006439282
Drug	medifoxamine	HTR1F HTR2A	2.09e-04	8	63	2	CID000036109
Drug	avitriptan	HTR1F HTR2A	2.09e-04	8	63	2	CID000133081
Drug	benzylguanidine	RIF1 LYST	2.09e-04	8	63	2	CID000016644
Drug	5-fluoro-alpha-methyltryptamine	HTR1F HTR2A	2.09e-04	8	63	2	CID000012834
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	FBLN1 ARVCF SCAPER CTIF RYR1	2.11e-04	196	63	5	5253_UP
Drug	5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA	FBLN1 PIK3CD BACH1 SCAPER TADA2A	2.11e-04	196	63	5	833_UP
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; PC3; HT_HG-U133A	RIF1 HTR2A ANK2 LYST BTRC	2.11e-04	196	63	5	5769_UP
Drug	6-mercaptopurine monohydrate; Down 200; 100uM; MCF7; HG-U133A	ANK2 ARVCF PIK3CD LDLR BTRC	2.11e-04	196	63	5	334_DN
Drug	Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	FBLN1 FBN2 SCAPER CTIF LYST	2.11e-04	196	63	5	1487_UP
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A	FBLN1 PIK3CD BUB1 CTIF RYR1	2.11e-04	196	63	5	6782_UP
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A	SCAPER CTIF TADA2A GPNMB BTRC	2.11e-04	196	63	5	3435_UP
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	FBLN1 TUT4 SCAPER LYST BTRC	2.11e-04	196	63	5	3342_DN
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A	AKAP9 ANK2 BACH1 GPNMB TESPA1	2.11e-04	196	63	5	4075_UP
Drug	Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A	FBN1 BUB1 PRR14L TADA2A LYST	2.11e-04	196	63	5	1810_UP
Drug	Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; HL60; HT_HG-U133A	ANK2 PIK3CD BACH1 SCAPER CPS1	2.16e-04	197	63	5	2994_DN
Drug	Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A	LUC7L3 PEX19 LTBP1 PRR14L TADA2A	2.16e-04	197	63	5	6232_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA	LUC7L3 LTBP1 PRR14L TADA2A LDLR	2.16e-04	197	63	5	1042_UP
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	HTR2A ANK2 SCAPER CTIF NRIP3	2.16e-04	197	63	5	3744_UP
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; PC3; HT_HG-U133A	RIF1 HTR2A AKAP9 ARVCF NRIP3	2.16e-04	197	63	5	3983_UP
Drug	Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A	ARVCF PIK3CD DIPK1A TADA2A LYST	2.21e-04	198	63	5	4798_DN
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A	TUT4 ARVCF TADA2A LYST BTRC	2.21e-04	198	63	5	5383_DN
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	ARVCF BUB1 SCAPER CTIF CPS1	2.21e-04	198	63	5	3842_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A	RIF1 ARVCF CTIF TADA2A GPNMB	2.21e-04	198	63	5	4301_UP
Drug	Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A	RIF1 FBLN1 ARVCF BUB1 SCAPER	2.21e-04	198	63	5	7322_UP
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A	FBLN1 ARVCF BACH1 CTIF RYR1	2.21e-04	198	63	5	2811_UP
Drug	5-aminosalicylic acid; Down 200; 100uM; MCF7; HG-U133A	BUB1 PEX19 PAK2 BIRC2 LDLR	2.21e-04	198	63	5	124_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A	FBN1 ANK2 BACH1 SCAPER RYR1	2.21e-04	198	63	5	4695_UP
Drug	thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	DNAJA3 KANK1 GTF3C1 CTIF CPS1	2.21e-04	198	63	5	6189_DN
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	FBLN1 HTR1F CTIF USP9Y RYR1	2.21e-04	198	63	5	2273_UP
Drug	CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A	FBLN1 FBN1 HTR2A BACH2 GPNMB	2.21e-04	198	63	5	3908_UP
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; MCF7; HT_HG-U133A	ARVCF SCAPER LTBP1 TADA2A LYST	2.26e-04	199	63	5	6840_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	RIF1 PIK3CD BUB1 TESPA1 BTRC	2.26e-04	199	63	5	3741_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; HL60; HG-U133A	KANK1 PIK3CD BUB1 LDLR BTRC	2.26e-04	199	63	5	1586_DN
Drug	tolbutamide; Down 200; 100uM; MCF7; HG-U133A	ARVCF PIK3CD BUB1 SCAPER LTBP1	2.26e-04	199	63	5	142_DN
Drug	Chrysin [480-40-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ARVCF BUB1 CPS1 USP9Y NRIP3	2.26e-04	199	63	5	5505_UP
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A	HTR1F CTIF PRR14L TADA2A LYST	2.26e-04	199	63	5	4334_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A	BACH2 PRKAA2 CPS1 BTRC RYR1	2.26e-04	199	63	5	2677_UP
Drug	Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	PRKAA2 BACH1 SCAPER TADA2A BTRC	2.31e-04	200	63	5	4505_DN
Drug	cisapride	FAT1 HTR1F HTR2A RYR1	2.64e-04	112	63	4	CID000002769
Drug	lactosyl lysosphingolipid	PSAP RYR1	2.68e-04	9	63	2	CID006439268
Drug	2,5-dimethoxy-4-iodoamphetamine	HTR1F HTR2A BTRC RYR1	3.12e-04	117	63	4	CID000001229
Drug	cyproconazole	FBN2 PSAP AKAP9 LUC7L3 PRKAA2 LDLR	3.31e-04	336	63	6	ctd:C093628
Drug	seganserin	HTR1F HTR2A	3.34e-04	10	63	2	CID000071767
Drug	LY344864	HTR1F HTR2A	3.34e-04	10	63	2	CID005311097
Drug	funiferine N-oxide	FBN1 FBN2 LTBP1	3.40e-04	49	63	3	CID000191631
Disease	Colorectal Carcinoma	KMT2C VPS18 FAT1 FBLN2 FBN2 AKAP9 ANK2 BUB1 OBSCN GPNMB	2.23e-06	702	63	10	C0009402
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN2	1.34e-05	3	63	2	DOID:65 (implicated_via_orthology)
Disease	scoliosis (is_implicated_in)	FBN1 FBN2	2.68e-05	4	63	2	DOID:0060249 (is_implicated_in)
Disease	eosinophil count	AKAP9 ARVCF COG6 PIK3CD DIPK1A ICE2 KIAA0232 BACH2 MKRN2 PAK2 FNIP1 CPS1	6.31e-05	1488	63	12	EFO_0004842
Disease	osteoarthritis, knee, body mass index	WSCD2 LTBP1 CPS1	9.33e-05	41	63	3	EFO_0004340, EFO_0004616
Disease	colorectal cancer (is_implicated_in)	FAT1 PIK3CD BUB1 SPOP	1.33e-04	121	63	4	DOID:9256 (is_implicated_in)
Disease	Colorectal Neoplasms	FAT1 FBLN2 FBN2 BUB1 GPNMB	3.17e-04	277	63	5	C0009404
Disease	Malignant neoplasm of breast	RIF1 AKAP9 ANK2 PRKAA2 OBSCN BIRC2 MACF1 CTIF GPNMB	4.39e-04	1074	63	9	C0006142
Disease	Romano-Ward Syndrome	AKAP9 ANK2	5.28e-04	16	63	2	C0035828
Disease	behavior or behavioral disorder measurement, personality trait	FBLN1 WSCD2	6.71e-04	18	63	2	EFO_0004365, EFO_0004782
Disease	glomerulonephritis (biomarker_via_orthology)	FBN1 LTBP1	8.32e-04	20	63	2	DOID:2921 (biomarker_via_orthology)
Disease	lymphocyte count	FBN1 ARVCF PIK3CD KIAA0232 BACH2 PRKAA2 PAK2 TADA2A CPS1 LYST	1.01e-03	1464	63	10	EFO_0004587
Disease	FEV/FEC ratio	FBLN1 KANK1 FBN1 ARVCF DIPK1A KIAA0232 BACH2 SCAPER LTBP1	1.14e-03	1228	63	9	EFO_0004713
Disease	Brugada Syndrome (disorder)	AKAP9 ANK2	1.20e-03	24	63	2	C1142166
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	MACF1 CPS1 LDLR	1.41e-03	103	63	3	EFO_0008595, EFO_0020944
Disease	peptide measurement	CACNA1B KANK1 SCAPER	1.66e-03	109	63	3	EFO_0010520
Disease	Cholestasis	KANK1 ALDH8A1 NFXL1	1.70e-03	110	63	3	C0008370
Disease	basophil count, eosinophil count	COG6 BACH2 PAK2 FNIP1	1.77e-03	241	63	4	EFO_0004842, EFO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISDFCQQMTDKCTTD	BACH1	721	O14867
QTVTVDFCQEMTDKC	BACH2	816	Q9BYV9
DFCQEMTDKCTTDEQ	BACH2	821	Q9BYV9
ECSKEQMLSCTQNID	BDP1	511	A6H8Y1
DLETQIECLMSDQEC	AKAP9	2326	Q99996
TVITDIKDESCCMTE	ALDH8A1	376	Q9H2A2
SVDNEMEDMIIQCCS	CFAP54	3026	Q96N23
KDTDNKSVENCVCIM	ARVCF	561	O00192
KQCTQATLDSCEENM	BUB1	631	O43683
VKEDAVLCCSMELQS	CTIF	516	O43310
VNVCDKCKISEEMSN	HTR1F	316	P30939
VCEKFECTESEVMNS	PRKAA2	296	P54646
ETVCLASTAMKTENC	BTRC	91	Q9Y297
TQNTVCSPVDVDEMC	GPNMB	436	Q14956
ITNIMAVICKESCNE	HTR2A	341	P28223
VMSECSLEKNERACI	CACNA1B	1426	Q00975
QASQDKVCSICMEVI	MKRN2	231	Q9H000
CFCMTDDKVDKTLEQ	ANK2	1346	Q01484
CSDVSACCEVESEVM	FAT1	4546	Q14517
MSKEQCCLSEEEIEQ	FIGNL1	581	Q6PIW4
QSGEDSKMLVCDTCD	KMT2C	396	Q8NEZ4
ENQVSIECDTTCKEM	NFXL1	816	Q6ZNB6
MADGVSCEDINECVT	FBLN2	711	P98095
SEANCKIMAQCEEEI	KIAA0232	1226	Q92628
AKMTCVDVNECDELN	LTBP1	1656	Q14766
VEMCDKSVSVEVSVC	KANK1	586	Q14678
SFAAQEKQMEVCEVC	LUC7L3	181	O95232
ACNQTAEMSCNKVEE	MACF1	2801	Q9UPN3
QELQQCDTDDDVAMC	OBSCN	5756	Q5VST9
TESKECRMVQEQCCH	FBLN1	56	P23142
TETCMDEAQIAAVCR	PAK2	336	Q13177
QHSVMCKICEQFEAE	PEX19	221	P40855
LESISEDVQAMSNCC	COG6	101	Q9Y2V7
VVRDADDNCVTVCNM	CPS1	636	P31327
DDNCVTVCNMENVDA	CPS1	641	P31327
MSCEVNECRKIESLE	ICE2	376	Q659A1
ASEDMKTCVDVNECD	FBN1	1271	P35555
ECQMISPSDCQEENA	FNIP1	646	Q8TF40
IFQDKCMNTTLTECD	IL10RB	61	Q08334
SSCESAKTVCEMEAV	LYST	2166	Q99698
SQDQTMCMDVDECER	FBN2	1926	P35556
KEFTVNIMDTCERCN	DNAJA3	226	Q96EY1
SCDQSTMKCTSEVIQ	DIPK1A	346	Q5T7M9
CESDQSVVECKEVLM	SCAPER	121	Q9BY12
LSCSEADENEMINCE	RYR1	4111	P21817
QSIACEMNELSCTNE	PRR14L	626	Q5THK1
CMEFSCDEVVSLIQK	MROH2A	1071	A6NES4
KSEEDDMILVSCQCA	NRIP3	101	Q9NQ35
QDVANQMCTKTKEEC	TADA2A	96	O75478
EESDTDEKCTICLSM	RNF165	286	Q6ZSG1
EENLCCEELSSKIMS	RIF1	726	Q5UIP0
QEERTCKVCMDKEVS	BIRC2	566	Q13490
TVMCEECANISTVKD	USP45	361	Q70EL2
KVMCEEALCSNLSVE	SPOPL	286	Q6IQ16
KVMCEDALCSNLSVE	SPOP	286	O43791
EEEDVQTAMACLASC	VPS18	766	Q9P253
LAEVCVEQCTFMDSK	PIK3CD	741	O00329
VEDEQVCCEALEVMT	USP9Y	1281	O00507
DVCQDCIQMVTDIQT	PSAP	196	P07602
ITDTTSIEKMSNCCE	ZDHHC21	206	Q8IVQ6
VFCCEEETQQRMSTV	TESPA1	361	A2RU30
QATNVSEAECDMECK	WSCD2	186	Q2TBF2
ESIQTDCSCREQMKQ	XKR5	666	Q6UX68
IMDQEKQEGVSTKCC	GTF3C1	641	Q12789
EQPVQCDEMDCTSQR	TUT4	761	Q5TAX3
CKDMSDEVGCVNVTL	LDLR	261	P01130